Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zucchetti

Showing results (411-420 of 479) with videos related to

Pageof 48
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 7, 2014
Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumorsJ-C Soria, F DeBraud, R Bahleda, et al.
Neurology|August 15, 2019
Cognitive impairment across ALS clinical stages in a population-based cohortAdriano Chiò, Cristina Moglia, Antonio Canosa, et al.
Plos One|October 12, 2017
Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insightsPaola Marmiroli, Beatrice Riva, Eleonora Pozzi, et al.
The Oncologist|March 29, 2014
Phase ib of sorafenib in combination with everolimus in patients with advanced solid tumors, selected on the basis of molecular targetsFrancesca Toffalorio, Gianluca Spitaleri, Chiara Catania, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 28, 2020
Corrections to "Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors"J-C Soria, F DeBraud, R Bahleda, et al.
Journal of Atrial Fibrillation|December 14, 2016
New Imaging Technologies To Characterize Arrhythmic SubstrateAntonio Dello Russo, Sergio Conti, Ghaliah Al-Mohani, et al.
Frontiers in Immunology|March 26, 2021
Blood Interferon-α Levels and Severity, Outcomes, and Inflammatory Profiles in Hospitalized COVID-19 PatientsMarco Contoli, Alberto Papi, Luca Tomassetti, et al.
Critical Care (London, England)|February 20, 2021
Markers of endothelial and epithelial pulmonary injury in mechanically ventilated COVID-19 ICU patientsSavino Spadaro, Alberto Fogagnolo, Gianluca Campo, et al.
Heart Rhythm|April 3, 2012
Fragmented and delayed electrograms within fibrofatty scar predict arrhythmic events in arrhythmogenic right ventricular cardiomyopathy: results from a prospective risk stratification studyPasquale Santangeli, Antonio Dello Russo, Maurizio Pieroni, et al.
Clinical and Translational Medicine|March 30, 2021
Time course of endothelial dysfunction markers and mortality in COVID-19 patients: A pilot studyFrancesco Vieceli Dalla Sega, Francesca Fortini, Savino Spadaro, et al.
Pageof 48

Showing results (411-420 of 479) with videos related to

Sort By:
Pageof 48
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 7, 2014
Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumorsJ-C Soria, F DeBraud, R Bahleda, et al.
Neurology|August 15, 2019
Cognitive impairment across ALS clinical stages in a population-based cohortAdriano Chiò, Cristina Moglia, Antonio Canosa, et al.
Plos One|October 12, 2017
Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insightsPaola Marmiroli, Beatrice Riva, Eleonora Pozzi, et al.
The Oncologist|March 29, 2014
Phase ib of sorafenib in combination with everolimus in patients with advanced solid tumors, selected on the basis of molecular targetsFrancesca Toffalorio, Gianluca Spitaleri, Chiara Catania, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 28, 2020
Corrections to "Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors"J-C Soria, F DeBraud, R Bahleda, et al.
Journal of Atrial Fibrillation|December 14, 2016
New Imaging Technologies To Characterize Arrhythmic SubstrateAntonio Dello Russo, Sergio Conti, Ghaliah Al-Mohani, et al.
Frontiers in Immunology|March 26, 2021
Blood Interferon-α Levels and Severity, Outcomes, and Inflammatory Profiles in Hospitalized COVID-19 PatientsMarco Contoli, Alberto Papi, Luca Tomassetti, et al.
Critical Care (London, England)|February 20, 2021
Markers of endothelial and epithelial pulmonary injury in mechanically ventilated COVID-19 ICU patientsSavino Spadaro, Alberto Fogagnolo, Gianluca Campo, et al.
Heart Rhythm|April 3, 2012
Fragmented and delayed electrograms within fibrofatty scar predict arrhythmic events in arrhythmogenic right ventricular cardiomyopathy: results from a prospective risk stratification studyPasquale Santangeli, Antonio Dello Russo, Maurizio Pieroni, et al.
Clinical and Translational Medicine|March 30, 2021
Time course of endothelial dysfunction markers and mortality in COVID-19 patients: A pilot studyFrancesco Vieceli Dalla Sega, Francesca Fortini, Savino Spadaro, et al.
Pageof 48